These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3123880)

  • 21. Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer.
    Myklebust AT; Godal A; Fodstad O
    Cancer Res; 1994 Apr; 54(8):2146-50. PubMed ID: 8174121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The novel multispecies Fc-specific Pseudomonas exotoxin A fusion protein α-Fc-ETA' enables screening of antibodies for immunotoxin development.
    Klausz K; Kellner C; Derer S; Valerius T; Staudinger M; Burger R; Gramatzki M; Peipp M
    J Immunol Methods; 2015 Mar; 418():75-83. PubMed ID: 25701195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential.
    Yu Y; Li J; Zhu X; Tang X; Bao Y; Sun X; Huang Y; Tian F; Liu X; Yang L
    Int J Nanomedicine; 2017; 12():1969-1983. PubMed ID: 28331319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer.
    Pai LH; Bookman MA; Ozols RF; Young RC; Smith JW; Longo DL; Gould B; Frankel A; McClay EF; Howell S
    J Clin Oncol; 1991 Dec; 9(12):2095-103. PubMed ID: 1960550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of Diphtheria and Pseudomonas Exotoxin A Immunotoxins and Evaluation of Their Cytotoxicity Effect on SK-BR-3, BT-474, and MDA-MB-231 Breast Cancer Cell Lines.
    Amoozadeh S; Hemmati M; Farajollahi MM; Akbari N; Tarighi P
    Cancer Invest; 2019; 37(10):546-557. PubMed ID: 31597492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomonas exotoxin A: from virulence factor to anti-cancer agent.
    Wolf P; Elsässer-Beile U
    Int J Med Microbiol; 2009 Mar; 299(3):161-76. PubMed ID: 18948059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibody C242-Pseudomonas exotoxin A. A specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice.
    Debinski W; Karlsson B; Lindholm L; Siegall CB; Willingham MC; FitzGerald D; Pastan I
    J Clin Invest; 1992 Aug; 90(2):405-11. PubMed ID: 1644913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical construction of immunotoxins.
    Ghetie V; Vitetta ES
    Mol Biotechnol; 2001 Jul; 18(3):251-68. PubMed ID: 11503519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced therapeutic efficacy of an immunotoxin in combination with chemotherapy against an intraperitoneal human tumor xenograft in athymic mice.
    Pearson JW; Sivam G; Manger R; Wiltrout RH; Morgan AC; Longo DL
    Cancer Res; 1989 Sep; 49(18):4990-5. PubMed ID: 2504482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotoxins containing Pseudomonas exotoxin that target LeY damage human endothelial cells in an antibody-specific mode: relevance to vascular leak syndrome.
    Kuan CT; Pai LH; Pastan I
    Clin Cancer Res; 1995 Dec; 1(12):1589-94. PubMed ID: 9815960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy of human cervical carcinoma with monoclonal antibody-Pseudomonas exotoxin conjugates.
    Roffler SR; Yu MH; Chen BM; Tung E; Yeh MY
    Cancer Res; 1991 Aug; 51(15):4001-7. PubMed ID: 1855216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of epitopes on a mutant form of Pseudomonas exotoxin using serum from humans treated with Pseudomonas exotoxin containing immunotoxins.
    Roscoe DM; Pai LH; Pastan I
    Eur J Immunol; 1997 Jun; 27(6):1459-68. PubMed ID: 9209499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys.
    Pai LH; Batra JK; FitzGerald DJ; Willingham MC; Pastan I
    Cancer Res; 1992 Jun; 52(11):3189-93. PubMed ID: 1591729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of antibody response to Pseudomonas exotoxin and an immunotoxin containing Pseudomonas exotoxin by 15-deoxyspergualin in mice.
    Pai LH; FitzGerald DJ; Tepper M; Schacter B; Spitalny G; Pastan I
    Cancer Res; 1990 Dec; 50(24):7750-3. PubMed ID: 2253218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An immunotoxin with increased activity and homogeneity produced by reducing the number of lysine residues in recombinant Pseudomonas exotoxin.
    Debinski W; Pastan I
    Bioconjug Chem; 1994; 5(1):40-6. PubMed ID: 8199233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon.
    Pearson JW; Hedrick E; Fogler WE; Bull RL; Ferris DK; Riggs CW; Wiltrout RH; Sivam G; Morgan AC; Groves E
    Cancer Res; 1990 Oct; 50(19):6379-88. PubMed ID: 2144790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A variant of exotoxin A that forms potent and specific chemically conjugated immunotoxins.
    Chaudry GJ; Fulton RJ; Draper RK
    J Biol Chem; 1993 May; 268(13):9437-41. PubMed ID: 8486636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant toxins containing the variable domains of the anti-Tac monoclonal antibody to the interleukin-2 receptor kill malignant cells from patients with chronic lymphocytic leukemia.
    Kreitman RJ; Chaudhary VK; Kozak RW; FitzGerald DJ; Waldman TA; Pastan I
    Blood; 1992 Nov; 80(9):2344-52. PubMed ID: 1421405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxins.
    Hexham JM; Dudas D; Hugo R; Thompson J; King V; Dowling C; Neville DM; Digan ME; Lake P
    Mol Immunol; 2001 Sep; 38(5):397-408. PubMed ID: 11684296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the influence of common antibiotics on the efficacy of a recombinant immunotoxin in tissue culture.
    Zhu Y; Weldon JE
    BMC Res Notes; 2019 May; 12(1):293. PubMed ID: 31133049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.